Please use the links below to search by the first letter of a expert's last name or use the tabs above to browse by health topic, date or sponsor.
James Berenson, M.D.
James Berenson, M.D. is the Founder, President & Chief Executive Officer of the Institute for Myeloma and Bone Cancer Research. Dr. Berenson has specialized in research related to myeloma and metastatic bone disease both in the basic and clinical areas for more than 25 years. He has been involved in many of the major breakthroughs that have brought new treatments for patients with these diseases resulting in both an improvement in the length and quality of their lives. After receiving a Bachelor of Science with Distinction from Stanford University, he earned his Doctorate in Medicine from the University of California at San Diego. Dr. Berenson completed his internship and residency in internal medicine at the University of Utah Medical Center and fellowships in hematology/oncology at the University of California at Los Angeles (UCLA). He is certified by the American Board of Internal Medicine in both internal medicine and medical oncology. Dr. Berenson has performed research as a member of the Departments of Medicine and Biological Chemistry at the UCLA School of Medicine and has served as Chief of Medical Oncology and Cancer Research as well as Director of Research at the Greater Los Angeles Veterans Administration Healthcare Systems. He has authored and co-authored numerous books, articles, and abstracts in critically renowned journals. Dr. Berenson serves as a member of the National Institutes of Health - Center for Scientific Review, Clinical Oncology Study Section and is a member of the Scientific Boards of the Multiple Myeloma Research Foundation and the International Myeloma Foundation. He also serves on both the Foundation and the Scientific Boards of the Leukemia, Lymphoma and Myeloma Society.
|12/14/2007||-||The Latest Myeloma News from the American Society of Hematology Meeting||Program Details >>|
|11/02/2007||-||Contemporary Issues in Relapsed-Refractory Myeloma||Program Details >>|
|Understanding Pre-Myeloma (MGUS)||Watch Now >>|
|ASCO Myeloma Update: More Promising Medicines on the Way||Watch Now >>|
|Understanding Myeloma News About Secondary Cancers and Clotting||Watch Now >>|
|Bone Health Management for Myeloma: More Active Living with Less Worry||Watch Now >>|
|Update on the Drug Development Pipeline for Myeloma||Watch Now >>|
|Ask Dr. Berenson||Watch Now >>|
|How to Limit the Side Effects When Living with Multiple Myeloma||Watch Now >>|
|The Latest in Myeloma||Watch Now >>|
|Myeloma Update from ASCO||Watch Now >>|
|A Leading Expert's Perspective on Myeloma News and Your Questions||Watch Now >>|
|Ask Dr. Berenson: Updates on Myeloma Treatment and Bone Health (August 2011)||Watch Now >>|